Latest news

Pfizer Inc (NYSE:PFE) has opted into the right to develop and commercialize LianBio’s (NASDAQ:LIAN) sisunatovir, a respiratory syncytial virus (RSV) therapeutic…

  Pfizer will now lead all development and commercialization activities in Mainland China, Hong Kong, Macau, and Singapore LianBio will receive a $20 million upfront payment, to be released from previously

  On Monday, 413 companies reached new 52-week lows.

  On Friday morning, 446 companies hit new 52-week lows.

Raymond James analyst Dane Leone maintains LianBio (NASDAQ:LIAN) with a Outperform and lowers the price target from $27 to $15.

  On Thursday, 1076 companies hit new 52-week lows.

Bristol Myers Squibb (NYSE:BMY) and 2seventy bio (NASDAQ:TSVT) announced positive topline results from KarMMa-3, a Phase 3 study…

  On Friday, 1043 companies hit new 52-week lows.

Gainers GTY Technology Holdings Inc. (NASDAQ: GTYH) shares climbed 115.2% to close at $6.09 as the company agreed to be acquired by GI Partners.

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite tumbling around 3% on Friday.